IMMEDIATE AND MIDTERM OUTCOMES OF PATIENTS WITH CEREBRAL ANEURYSMS TREATED WITH MATRIX1 AND MATRIX2 COILS
Authors:
- Akira IshiiAIAkira Ishii
- Yuichi MurayamaYMYuichi Murayama
- Yih-Lin NienYNYih-Lin Nien
- Ichiro YukiIYIchiro Yuki
- P. Henry AdaponPAP. Henry Adapon
- Robert KimRKRobert Kim
- Reza JahanRJReza Jahan
- Gary DuckwilerGDGary Duckwiler
- Fernando ViñuelaFVFernando Viñuela
- 1 December 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 63 (6) , 1071-1079
Abstract
Recanalization after coil embolization of cerebral aneurysms remains a limitation of this progressively accepted modality. The Matrix detachable bioabsorbable coil (Boston Scientific Neurovascular, Natick, MA) was developed to overcome this limitation. We report a single-center experience using first- and second-generation Matrix coils. Immediate and midterm angiographic outcomes of 235 consecutive patients with 250 aneurysms treated with Matrix coils were reviewed retrospectively. The first 16 aneurysms included in the postmarket Acceleration of Connective Tissue Formation in Endovascular Aneurysm Repair (ACTIVE) study were treated exclusively with the Matrix coil, as per protocol. The next 234 aneurysms were treated in combination with bare platinum coils, stents, and the balloon-assisted technique. First-generation Matrix coils were used in 155 aneurysms (Matrix1 group) and second-generation Matrix coils were used in 79 aneurysms (Matrix2 group). Outcomes of the 3 groups were compared. Immediate complete obliteration was achieved in 12.5% of the ACTIVE group aneurysms, 32.9% of the Matrix1 group, and 43.0% of the Matrix2 group. Overall, 87 (34.8%) aneurysms were completely occluded acutely. Procedure-related morbidity and mortality were 2.4 and 0%, respectively. Follow-up (median, 7.9 months) angiograms were obtained for 186 (74.4%) aneurysms. Complete obliteration of aneurysms was confirmed in 26.7% of the ACTIVE group, 53.4% of the Matrix1 group, and 64.2% of the Matrix2 group. Recanalization was observed in 33.3% of the ACTIVE group, 16.9% of the Matrix1 group, and 9.4% of the Matrix2 group. The overall recanalization rate was 16.1%. Use of Matrix2 coils resulted in improved mechanical performance and anatomic outcome compared with Matrix1 coils. However, practitioners must be familiar with the mechanical characteristics of the Matrix coils, which are different from those of bare platinum coils.Keywords
This publication has 15 references indexed in Scilit:
- EMBOLIZATION OF INTRACRANIAL ANEURYSMS WITH HYDROGEL-COATED COILSNeurosurgery, 2007
- Embolization of Intracranial Aneurysms With Hydrogel-Coated Coils Versus Inert Platinum CoilsStroke, 2006
- Durability of Aneurysm Embolization with Matrix Detachable CoilsNeurosurgery, 2006
- Repeat Endovascular Treatment in Post-Embolization Recurrent Intracranial AneurysmsNeurosurgery, 2006
- International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusionThe Lancet, 2005
- Polyglycolide/Polylactide-Coated Platinum Coils for Patients With Ruptured and Unruptured Cerebral AneurysmsStroke, 2005
- Chemical Meningitis after Cerebral Aneurysm Treatment Using Two Second-generation Aneurysm Coils: Report of Two CasesNeurosurgery, 2004
- Matrix and Bioabsorbable Polymeric Coils Accelerate Healing of Intracranial AneurysmsStroke, 2003
- Guglielmi Detachable Coil embolization of cerebral aneurysms: 11 years' experienceJournal of Neurosurgery, 2003
- International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trialThe Lancet, 2002